Intracavernous self-injection vasoactive drugs treatment impotence experience cases patients impotence etiologies months institution intracavernous self-injection therapy vasoactive drugs papaverine alpha-blockers Ceritine new multilevel drug patients followup visits patients sexual activity dropout rate episodes prolonged erections patients injections patients complications percentage patients nodules permanent deformations cases intracavernous fibrosis percentage satisfied patients satisfaction index Improvement spontaneous erections sexual intercourse cases self-injections dependent 